Results 141 to 150 of about 24,027 (216)

Safety of Dupilumab and Risk of Cutaneous T‐Cell Lymphoma in Pediatric Patients With Atopic Dermatitis: A Data‐Driven Guide to Counseling Patients and Families

Pediatric Dermatology, EarlyView.
ABSTRACT Recent publications reporting increased cutaneous T‐cell lymphoma (CTCL) risk with dupilumab in atopic dermatitis (AD) have sparked debate, amplified by media coverage linking dupilumab to lymphoma. These concerns have reached pediatric populations, where we observe increasing parental hesitancy about initiating dupilumab for their children ...
Maria Gnarra Buethe, Tyler Sy, Lawrence F. Eichenfield   +2 more
wiley   +1 more source

Clinical Efficacy of Probiotic‐Based Ear Drops Containing Lactobacilli in Canine Erythroceruminous Otitis Externa: An Open Label, Multicentre Study

Veterinary Dermatology, EarlyView.
Background: Otitis externa (OE) represents a common clinical problem in dogs. Allergic dogs exhibit reduced diversity of the otic microbiota, and inflammation‐induced changes in the ear canal microenvironment result in a further decline in microbial biodiversity.
Isaac Carrasco, Josep Homedes, Antonio Arcas, Shea Beasley, Marta Salichs   +4 more
wiley   +1 more source

Lack of improvement after short‐term topical antistaphylococcal endolysin SA.100 therapy in patients with mild‐to‐moderate atopic dermatitis: Results from a randomized, vehicle‐controlled trial

British Journal of Clinical Pharmacology, Volume 92, Issue 7, Page 2409-2413, July 2026.
Abstract Atopic dermatitis (AD) is a chronic immune‐mediated inflammatory skin disease. An overgrowth of Staphylococcus aureus (S. aureus) and decreased microbial diversity is apparent in 70%–90% of AD patients. SA.100 is a recombinant endolysin targeting S. aureus that might be a novel treatment for patients with mild‐to‐moderate AD.
Laura W. J. van der Meulen, Menthe E. Bergmans, Salma Assil, Ismahaan Abdisalaam, Rianne Rijneveld, Erica S. Klaassen, Alexa J. Tibboel, Thorsten Brach, Bjorn L. Herpers, Johan Frieling, Benthe Freyee, Karin Platenkamp, Mariette E. van Poelgeest, Robert Rissmann, Martijn B. A. van Doorn, Tessa Niemeyer – van der Kolk   +15 more
wiley   +1 more source

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 7, Page 1137-1161, July 2026.
Autoimmune blistering disorders (AIBDs) in children are rare, challenging to diagnose and treat and often require immunosuppressants. Until now, no paediatric care guidelines existed. The EADV Task Force for AIBDs has developed the consensus‐based recommendations, enabling physicians to adopt a uniform, tailored treatment strategy to improve outcomes ...
A. Nanda, B. Tedbirt, C. Bodemer, M. C. Bolling, M. El Hachem, M. Nikolić, E. Benton, M. Caproni, D. De, D. Didona, K. Drenovska, M. Goebeler, M. Hertl, B. Horváth, M. Kasperkiewicz, D. Kiritsi, M. Larralde, A. V. Marzano, J. Meijer, D. F. Murrell, J. Powell, E. Sprecher, N. S. Chandran, M. M. Tomayko, S. Uzun, N. van Beek, H. Ott, A. Patsatsi, A. Torrelo, A. Welfringer‐Morin, E. Schmidt, P. Joly   +31 more
wiley   +1 more source

Diagnostic concordance of dermatopathology and PCR in differentiating eczema from psoriasis

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 7, Page 1227-1237, July 2026.
Distinguishing psoriasis from eczema is challenging due to overlapping clinical and histological features. This study shows substantial inter‐observer variability among dermatopathologists and demonstrates that a NOS2‐/CCL27‐based molecular test, including a fully automated platform, provides more accurate and reproducible diagnoses, particularly in ...
Andrea Schmitt, Susanne Proksch, Ludwig Gutzweiler, Sandra Roth, Marcella Engler, Cornelia S. L. Müller, Andreas Volz, Andreas W. Arnold, Monika Šedivcová, Adriana Bernklauova, Miroslav Dura, Denisa Kacerovska, Katja Technau‐Ihling, Christian Ihling, Christiane Rakozy, Wiebke Pruessmann, Thomas Leibing, Maria Isabel von Eichborn, Johannes Kern, Elisabeth Oms, Stefanie Eyerich, Kilian Eyerich, Helmut Laaff, Natalie Garzorz‐Stark, Kristin Technau‐Hafsi   +24 more
wiley   +1 more source

Efficacy and Safety of Supramolecular Salicylic Acid Combined With Intense Pulsed Light for Rosacea: A Split‐Face Trial

Journal of Cosmetic Dermatology, Volume 25, Issue 7, July 2026.
ABSTRACT Background Rosacea is a chronic inflammatory skin disorder with a global prevalence of approximately 5.46%, significantly impairing patients' quality of life and mental health. We aimed to assess the efficacy and safety of supramolecular salicylic acid (SSA) peeling combined with intense pulsed light (IPL) for rosacea and its impact on skin ...
Meifang Wang, Ansheng Tan, Fenglin Zhuo
wiley   +1 more source

Terra Firma-Forme Dermatosis Presenting With Unusual Features: A Case Report. [PDF]

Cureus
Alalyani MA, Alaseeri KM, Alqurashi SO, Al Hawsawi K.   +3 more
europepmc   +1 more source

Dermatosis Neglecta Localized to the Periumbilical Region: A Case Report. [PDF]

Clin Cosmet Investig Dermatol
Huang Z, Zhang R.
europepmc   +1 more source

Dupilumab Beyond the Airway: Decreased Morbidity in a Real‐World Analysis

International Forum of Allergy &Rhinology, Volume 16, Issue 6, Page 607-614, June 2026.
ABSTRACT Background Post hoc analyses of clinical trials have characterized dupilumab's adverse effects, yet the real‐world impact in chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma is not well described. This study aims to characterize the risks of lymphoma, cardiovascular events, eosinophilia, joint pain, inflammatory arthritis, and ...
Emma J. Anisman, Spencer Short, Emma Tam, Benjamin F. Bitner, Abdulghafoor Alani, Marc Rosen, Mindy Rabinowitz, Damaris Pena Evertz, Elina Toskala, Gurston G. Nyquist   +9 more
wiley   +1 more source

Acquired perforating dermatosis associated with uremic pruritus treated with dupilumab monotherapy: A case report. [PDF]

JAAD Case Rep
Mubarak S, AlEnezi H, AlKandari DI, Mosbeh AS, AlAlawi G.   +4 more
europepmc   +1 more source